Congenital Heart Disease: General Principles and Imaging


Introduction

Although rare, with an incidence of 8 per 1000 births, congenital heart disease (CHD) has increased in prevalence due to the success of surgical and medical management in childhood. A significant proportion of patients with repaired CHD surviving to adulthood fall under the care of cardiologists outside tertiary centres for congenital cardiac care. Specialist cardiovascular and general radiologists require an understanding of the underlying morphological abnormalities and their physiology, methods of repair and how potential complications may be detected and assessed in their practice, using appropriate imaging techniques, such as echocardiography, magnetic resonance imaging (MRI), cardiac magnetic resonance (CMR) and computed tomography (CT).

CHD is any developmental malformation of the heart. The spectrum of disease falling into this classification ranges from simple lesions—for example bicuspid aortic valve—through to more complex diseases involving single ventricle lesions, such as hypoplastic left-heart syndrome. The underlying causes of CHD remain relatively poorly understood, although the epidemiology suggests a genetic basis contributing to the majority of CHD. Aneuploidies—for example, trisomy 21 (Down syndrome, septal defects) and monosomy X (Turner syndrome, bicuspid aortic valve and coarctation)—are the earliest identified causes and account for 10%–20% of CHD. Copy number variations (small to large deletions or duplications) lead to altered dosage of genes and may represent another important mechanism; an example is Del22q11, which causes DiGeorge syndrome (interrupted aortic arch, tetralogy of Fallot (TOF), truncus arteriosus). Unfortunately, the cause of CHD in most patients remains unknown.

Clinical Presentation

The clinical presentation of CHD in infancy may be dominated by a number of physiological states.

  • 1.

    Left-to-Right Shunts: Redirection of blood from the systemic (left) to the pulmonary circulation (right) may occur at atrial, ventricular or great vessel level. A proportion of already oxygenated blood is recirculated to the lungs with each heartbeat, resulting in inefficiency. The volume of the shunt and its location accounts for the observed signs. Chambers and vessels receiving the excessive volume enlarge and high pulmonary blood flow results in pulmonary plethora. Typical examples include atrial septal defects (ASDs), ventricular septal defects (VSDs) and patent ductus arteriosus (PDA). Patients are pink but increasingly breathless with larger shunts.

  • 2.

    Compromised Systemic Perfusion: This may result from low stroke volume of a systemic ventricle (hypoplastic left-heart syndrome), outflow tract obstruction (critical aortic stenosis (AS)) or aortic obstruction (interrupted aortic arch or coarctation). The clinical picture is one of poor peripheral perfusion, with low-pulse volume; patients may be pink or blue (cyanotic). The ductus arteriosus may provide an effective temporary bypass for the obstruction, facilitating systemic perfusion with deoxygenated or mixed blood; however, as the duct closes (some days after birth), life-threatening systemic or lower body hypoperfusion ensues and, often, pulmonary venous hypertension. Therapy is directed at maintaining the patency of the arterial duct using intravenous prostaglandins, intensive care for critically ill patients and planning for surgical relief of the obstruction.

  • 3.

    Pulmonary Venous Congestion: Obstruction to pulmonary venous return results in increased pulmonary venous pressure (elevated pulmonary capillary wedge pressure); at progressively higher transvascular gradients, oncotic pressure is exceeded and extravasation of fluid into the interstitial and alveolar space occurs. Obstruction may occur in the pulmonary venous pathway (total anomalous pulmonary venous connection, TAPVD), in the atrium (cor triatriatum) or at the level of the left ventricle (LV) inflow (supravalvular, valvular or subvalvular mitral stenosis or mitral regurgitation). Pulmonary venous congestion may also occur as a function of elevated left atrial pressure secondary to LV diastolic dysfunction; increased LV end diastolic pressure (valve disease, aortic coarctation, myocardial disease). The degree of pulmonary venous hypertension determines the clinical presentation. Patients with severe obstruction may present with hypoxia, cyanosis and dyspnoea caused by pulmonary oedema, whilst patients with less severe obstruction may remain pink but may present later with failure to thrive.

The following three physiological states predominantly account for patients with cyanosis.

  • 4.

    Low Pulmonary Blood Flow: Reduction in pulmonary blood flow is commonly caused by obstruction to outflow from the right ventricle (RV), e.g. TOF or severe pulmonary stenosis (PS). The increased resistance to RV outflow results in a redirection of systemic venous return to the left heart (right to left shunt) via an interatrial communication (patent foramen ovale or ASD) or a VSD. Elevated pulmonary vascular resistance (PVR) without anatomical obstruction may also result in shunt redirection. As lung function is normal, any pulmonary venous blood returns to the left atrium fully saturated and mixes with the shunted systemic venous blood; however, because pulmonary flow is so low, there is insufficient oxygenated blood in the mix, resulting in cyanosis.

  • 5.

    Parallel Circulations: This occurs in transposition of the great arteries (TGA), where the aorta arises from the morphological right ventricle and the pulmonary artery from the left ventricle. In this condition, deoxygenated systemic venous return recirculates into the aorta and the oxygenated pulmonary venous return recirculates to the pulmonary artery, a situation clearly incompatible with life. Patients can only survive if there is sufficient mixing of the streams (shunt); this can occur best at atrial level through a large interatrial communication, less well at ventricular level (via a VSD) and even less well at great vessel level (via a PDA). Critical cyanosis may be managed medically by maintaining patency of the PDA by prostaglandins, but may require the creation of an artificial interatrial communication using cardiac catheterisation until definitive treatment by surgically switching the great vessels.

  • 6.

    Intracardiac Mixing: Complete intracardiac mixing of blood may occur at atrial level (common atrium), ventricular level (all univentricular hearts) or great artery level (common arterial trunk). Patients are expected to be mildly cyanosed, depending on the relative amount of deoxygenated blood in the mix, and breathless, according to the amount of pulmonary blood flow.

Later Clinical Presentation

The majority of adult patients with CHD are survivors from childhood. This group may present with an interesting array of problems related to residual lesions or deteriorations of their initial repair or palliation (heart failure, valve regurgitation, conduit stenosis, baffle leaks). They require life-long surveillance for anticipated problems arising from the ‘unnatural history’ of their underlying disorder.

New presentations of CHD continue beyond infancy into adulthood, usually because the underlying disorder has not yet produced symptoms. Common lesions include left-right shunts, such as ASDs, VSDs or partial anomalous pulmonary venous drainage, which only begin to be symptomatic in older patients; milder forms of LV or aortic obstruction such as coarctation of the aorta or valvular AS, which did not compromise systemic perfusion, may progress and become symptomatic in later childhood or adulthood; and milder forms of RV obstruction such as PS. A very rare late presentation of CHD is congenitally corrected TGA (atrioventricular (AV) and ventriculo-arterial discordance). Here, the right atrium connects to the left ventricle, then the pulmonary trunk, and the left atrium to the right ventricle, then the aorta. Whilst blood flow is ‘normal’, the right ventricle is the systemic ventricle and may fail late in life or even found to be undiagnosed until a post-mortem study.

An important presentation for unrepaired CHD is that of pulmonary arterial hypertension (PAH). PAH is a common complication of adult congenital heart disease (ACHD), affecting up to 10% of patients. PAH related to CHD is characterised by a rise in PVR with normal left atrial pressure. It is typically the result of pulmonary vascular disease caused by chronically elevated pulmonary arterial pressures in patients with large post-tricuspid defects such as VSDs, PDAs or aortopulmonary windows. Chronic pressure and volume load cause proliferative lesions to develop in the small muscular pulmonary arteries, which result in elevated PVR. Clinical features include signs of elevated pulmonary artery (PA) pressure and subpulmonary (usually RV) maladaptation ( Fig. 13.1 ).

Fig. 13.1, A 7-Year-Old Child With Pulmonary Arterial Hypertension and an Atrial Septal Defect.

Clearly, life-limiting conditions such as parallel circulation, significant shunts, severe intracardiac mixing or compromised systemic perfusion would not normally be expected beyond childhood.

Summary Box: Major Modes of Clinical Presentation of Congenital Heart Disease

  • Left-to-right shunt (e.g. ASDs, VSDs, PDA).

  • Compromised systemic perfusion (e.g. critical aortic stenosis).

  • Pulmonary venous congestion (e,g, obstructed TAPVD).

  • Low pulmonary blood flow (e,g, tetralogy of Fallot).

  • Parallel circulation (e,g, transposition of the great arteries).

  • Intracardiac mixing (e,g, truncus arteriosus).

ASDs , Atrial septal defects; PDA , patent ductus arteriosus; TAPVD , total anomalous pulmonary venous connection; VSDs , ventricular septal defects.

Morphological Description and Sequential Segmental Analysis

A significant diversity of morphological abnormalities may be responsible for the physiological phenomena described above and although initial management of an infant simply requires correct classification of the initial physiological pattern, subsequent surgical correction and medical management requires a precise anatomical diagnosis. The potential intrinsic complexity of CHD necessitates a systematic scheme of nomenclature that captures precisely the unique anatomy of each patient, called sequential segmental analysis. Using this approach, the clinician describes how the components of the heart and blood vessels are connected. This entails describing atrial situs (location of the atrial chambers and whether they are of left or right morphology), atrioventricular (AV) connections, ventriculo-arterial (VA) connections and other associated lesions in turn. Any cross-sectional imaging technique may be used for this purpose but transthoracic echocardiography is most commonly used for routine inpatient and outpatient assessment. In more complex lesions or when echocardiography provides an inadequate assessment (e.g. poor acoustic windows), CMR represents a powerful non-invasive technique giving morphological and haemodynamic information that echocardiography alone cannot provide.

Sequential Segmental Analysis

Step 1—Atrial Situs

Atrial situs is determined by an assessment of the morphology of each atrial appendage. Correct identification of the atrium allows the subsequent determination of the AV connection. The atrial appendages are the most consistent feature of the atrial mass; indeed, the venous attachments to each atrial chamber can form a variety of combinations. The right atrial appendage is a triangular shape, with a broad base and prominent pectinate muscles that extend around the right AV valve, whilst the left atrial appendage is a more elongated, tubular structure and has less extensive pectinate muscles that are confined within the appendage.

The most common lesions involve inversion of situs, or isomerism of the left or right atrial appendages. The non-cardiac thoracic and abdominal organs usually (but not always) demonstrate a similar ‘sidedness’ to that of the atrial chambers.

In the normal heart the morphological right atrium is located to the right of the morphological left atrium (situs solitus). The right lung is trilobed, with a shorter, early-branching bronchus and the left lung is bilobed. In addition, the inferior vena cava (IVC) is to the right of the abdominal aorta, with a right-sided liver and left-sided spleen.

In situs inversus the mirror image of the normal anatomy is present.

Isomerism of the left atrial appendages is usually associated with bilateral bilobed lungs, polysplenia and IVC interruption. Isomerism of the right atrial appendages is usually associated with bilateral triilobed lungs, asplenia and a midline liver. In isomeric lesions there is often a common AV junction (instead of two separate and offset left and right junctions) with varying degrees of AV septal defect (AVSD). Gut malrotation is associated with both right and left-sided isomerism.

Step 2—Ventricular Morphology

Determination of ventricular morphology allows analysis of AV and ventriculo-arterial connections. An AV connection is described as ‘concordant’ when the atria are connected to the expected ventricle (i.e. left atrium with left ventricle and right atrium with right ventricle); ‘discordant’ if the left atrium is connected to the right ventricle and right atrium to the left ventricle; ‘ambiguous’ if there is isomerism of the atrial appendages (e.g. two morphologically right atria connected to a left and right ventricle, respectively (one connection is concordant, the other discordant)); and, finally, ‘univentricular’ if both atria predominately connect to a single ventricle. Irrespective of AV concordance, the AV valve is always concordant with the ventricle—that is the tricuspid valve connects to the morphological right ventricle and the mitral valve connects to the morphological left ventricle.

The most distinguishing feature of the tricuspid valve is the direct attachments to the septum of cords from the septal leaflet. Unlike the tricuspid valve, the mitral valve has no direct septal attachments. The septal insertion of the tricuspid valve is more apical (apically ‘offset’) than that of the mitral valve and these features aid determination of the ventricular morphology. The muscular structure of the ventricles also differs, with the RV being more trabeculated than the LV, with a muscular infundibulum and mid-ventricular ‘moderator band’. Although they are different in normal subjects, the size, shape and degree of trabeculation of the ventricles are not good indicators of ventricular origin, as all are dependent on load effects.

Step 3—Ventriculo-Arterial Connection

Description of ventriculo-arterial connections represents the final element of sequential segmental analysis. This entails describing how each great vessel (aorta, pulmonary artery [PA], or common trunk) is connected to its respective ventricle. A ventriculo-arterial connection may be concordant (RV-PA, LV-aorta), discordant (RV-aorta, LV-PA), double outlet (e.g. RV-PA and aorta) or single outlet (e.g. LV and RV to common arterial trunk). The aorta and pulmonary arteries are defined by their typical branching patterns. Three-dimensional balanced steady-state free-precession (b-SSFP) and contrast-enhanced magnetic resonance angiography (MRA) techniques are particularly useful in determining the arrangement of the great vessels and the connections with their respective ventricles.

Step 4—Identification of Other Abnormalities

Other abnormalities to be considered include abnormal systemic and pulmonary venous connections, intracardiac shunts, valvar abnormalities and vascular abnormalities (PDA, right/left aortic arch, coarctation/interruption or pulmonary arterial abnormalities).

In general, most congenital cardiac lesions are single abnormalities that are easily described; however, almost any combination of abnormalities and connections can occur, and using the sequential segmental analysis method, the description of all conceivable combinations and diagnoses is possible. For more advanced reading, the reader is referred to the textbook Paediatric Cardiology by Anderson and colleagues (see Further Reading).

Summary Box: Summary of Sequential Segmental Analysis

  • 1.

    Describe the atrial arrangement.

  • 2.

    Describe the type of atrioventricular connection.

  • 3.

    Describe the ventriculo-arterial connection.

  • 4.

    Describe the position of the heart (particularly if abnormal or unexpected).

  • 5.

    Describe associated abnormalities (e.g., venous abnormalities, septal defects, valvar lesions, great vessel and coronary abnormalities).

  • 6.

    Describe acquired or iatrogenic abnormalities

Physiological and Functional Assessment

Whilst the correct morphological analysis is a critical first step, it must be incorporated into a complete physiological assessment to understand the clinical problem. It is helpful to briefly consider a few parameters relating to normal cardiac function, which are commonly calculated by techniques such as CMR.

  • Stroke Volume: This is the volume of blood (mL) pumped (displaced) by a ventricle with each heartbeat. The displaced volume is calculated by subtracting the volume of the ventricular cavity at end diastole from the volume at end systole. In the normal heart the stroke volume for each ventricle is the same and is also the same as the forward flow in the associated great artery. It may not be the same in the presence of a shunt or a regurgitant valve. Here, discrepancies in interventricular volumes or great artery flows help locate and quantify the severity of shunts and valve regurgitation.

  • Cardiac Output: This is how much blood each ventricular chamber pumps in 1 minute (L/min). It is calculated by multiplying the stroke volume (or great artery flow (mL)) by the heart rate (stroke (beat)/min). Cardiac output is increased by physiological stress (e.g., exercise that increases both heart rate and stroke volume) and depressed in conditions that reduce either heart rate (bradyarrhythmias) or stroke volume (dilated cardiomyopathy, heart failure).

  • Ejection Fraction: A useful assessment of gross systolic cardiac function is the percentage of blood ejected from the heart during each beat. This is calculated by dividing the stroke volume by the end-diastolic volume. Ejection fraction may be decreased if the systolic performance of the ventricle is impaired (cardiomyopathy).

  • Flow: Using phase-contrast MRI, blood flow and its direction (mL/beat) across valves and vascular structures can be quantified. In valvar regurgitation, backward flow can be measured and expressed as a regurgitant fraction (backward flow/forward flow). Combined with cine imaging, flow data can be used to calculate and localise intra-/extracardiac shunts.

Non-Invasive Imaging Techniques

Imaging is fundamental to the diagnosis of CHD and is required at all stages of patient care. An ideal non-invasive technique for imaging of CHD should be able to accurately and reproducibly delineate all aspects of the anatomy, including intracardiac abnormalities and abnormalities of extracardiac vessels; evaluate physiological consequences of CHD such as measurement of blood flow and pressure gradients across stenotic valves or blood vessels; be cost-effective and portable; provide data from fetal life to adulthood; not cause excessive discomfort and morbidity; and not expose patients to harmful effects of ionising radiation. No single technique has fulfilled these entire requirements and in the delivery of a CHD service, the imaging techniques discussed below play an important complementary role.

Echocardiography

Echocardiography is the initial imaging technique used in the evaluation of patients with suspected CHD and should always be performed before other techniques are used. In most patients, echocardiography alone provides sufficient information to complete the diagnostic evaluation using a sequential segmental and functional analysis. In UK clinical practice, paediatric cardiologists have traditionally performed echocardiography; however, more recently, neonatologists and radiologists have begun to use echocardiography in patients with suspected CHD where paediatric cardiology services are not immediately available. Cardiac anaesthetists also increasingly perform perioperative assessment using transoesophageal echocardiography. For a more comprehensive discussion of echocardiography in CHD, the reader is referred to Lai et al (see Further Reading).

Magnetic Resonance Imaging

As previously alluded, CMR probably provides the most comprehensive assessment available from a single non-invasive imaging technique but its immobility, cost and limited availability constrain its general applicability. In our clinical practice it is used to define the morphology and physiology of the most complex CHD cases as well as providing routine surveillance for patients with repaired CHD such as TOF and TGA. Extracardiac anatomy, including the great arteries and systemic veins, can be delineated with high spatial resolution. Vascular and valvular flow can be assessed, shunts can be quantified and myocardial function can be measured accurately with high reproducibility, regardless of ventricular morphology. Finally, CMR provides high-resolution, isotropic, three-dimensional data sets. This allows for reconstruction of data in any imaging plane, facilitating visualisation of complex cardiac anomalies without the use of ionising radiation.

The majority of CMR images are acquired using cardiac (vectorcardiograph) gating during a single breath-hold to reduce the artefacts associated with cardiac and respiratory motion. For a complex case, CMR is performed over approximately 1 hour, although this time can be considerably reduced if a focused question is being addressed or by the incorporation of newer real-time sequences.

Imaging sequences can be broadly divided into:

  • ‘Black blood’ spin-echo images, where signal from blood is nulled and thus not seen—for accurate anatomical imaging.

  • ‘White blood’ gradient-echo or SSFP images, where a positive signal from blood is returned—for anatomical, cine imaging and quantification of ventricular volumes, mass and function.

  • Phase-contrast imaging, where velocity information is encoded for quantification of vascular flow, including newer 4D (or 7D) phase-contrast imaging.

  • Contrast-enhanced MRA, where non-echocardiogram (ECG)-gated 3D data are acquired after gadolinium contrast medium has been administered for thoracic vasculature imaging.

  • Tissue characterisation imaging, where innate contrast between normal myocardium and disease can be imaged: T 1 mapping and extracellular volume imaging, T 2 oedema imaging, T 2 * iron deposition imaging, late gadolinium enhancement fibrosis and necrosis imaging.

All these sequences can be acquired in a single breath-hold, reducing the overall time in the CMR machine and enabling the acquisition of accurate data in the majority of patients. Importantly, ‘white blood’ cine images can be acquired in a continuous short-axis stack along the heart, enabling accurate quantification of RV and LV function.

Imaging should be performed in the presence of a cardiovascular MRI clinician in conjunction with an MRI technician to ensure that the appropriate clinical questions are answered. A comprehensive treatment of cardiovascular MRI is provided in the textbook by Bogaert and colleagues (see Further Reading).

Computed Tomography

Cardiac CT is now well established for the assessment of the thoracic vasculature and large and small airways. Recent advances in multidetector CT (MDCT) with high-pitch spiral and volumetric scan modes have resulted in significant advances in spatial and temporal resolution and a decrease in radiation dose, often less than 1 mSv.

Most studies are fully diagnostic without ECG gating. ECG-triggered and ECG-gated acquisitions should therefore only be utilised when cardiac motion may produce non-diagnostic images. Newer-generation scanners permit rapid imaging with minimal motion artefact and thus remove the need for gated scans and general anaesthesia. General anaesthesia may still be needed to control breathing when detailed coronary artery imaging is required.

The route and contrast administration protocol are critical to successful imaging. The right upper limb in most cases provides a good site of administration of contrast (avoiding streak artefact from contrast in the innominate vein, which can obscure head and neck vessels). Generally, a biphasic injection protocol using a power injector will be appropriate, deploying a neat contrast bolus (1–3 mL/kg) followed by saline chaser. In neonates and low-bodyweight children requiring small absolute contrast doses, short contrast transit time increases the risk of suboptimal opacification of essential structures. Using the full available contrast dose, reducing the injection rate and mixing the contrast bolus with saline increases the transit time. Empirically, dilution with saline to 70%–80% contrast concentration gives good opacification.

Visual bolus triggering from a low-resolution monitoring scan is our favoured approach for timing of acquisition because it more reliably ensures opacification of the appropriate cardiac structures. This does incur a small, added radiation dose, which can be minimised by delaying monitoring toward the end of the injection and reducing the frequency of monitoring scans. A pre-scan timing bolus is often avoided because it utilises part of the contrast bolus available and increases the radiation dose.

We currently use MDCT for the following indications in patients with CHD:

  • Thoracic aorta disease, including vascular rings where airway information is critical. Aim for a narrow bolus via right arm injection to avoid streak artefact from innominate vein over head and neck vessels.

  • Pulmonary arterial disease. Aim for a prolonged contrast transit time to ensure all sources of pulmonary blood supply are evaluated. The infradiaphragmatic area should also be imaged because collateral vessels may arise here. If thromboembolic disease must be excluded, a rapid undiluted bolus must reach the pulmonary arteries—this can be extremely challenging in cavo-pulmonary connections.

  • Coronary artery abnormalities. ECG-triggered or ECG-gated protocols may be necessary. Pharmacological heart rate reduction may be required in cases of very high heart rate.

  • Pulmonary venous abnormalities. Aim for a prolonged contrast transit time to ensure there has been ample time for delayed filling of venous collaterals or slow flow segments. Care should be taken to avoid very dense contrast that may cause streak artefact and obscure anomalous entry points into the systemic venous system. The scan should include the hepatic inferior vena cava in suspected infra-diaphragmatic total anomalous pulmonary anomalous connections or partial anomalous pulmonary venous drainage to the hepatic inferior vena cava.

  • Patients with implants or devices that cannot be imaged by CMR. Imaging should take account of the material to be imaged. Higher kVp, edge-enhancing reconstruction kernels and iterative reconstruction improve the diagnostic accuracy.

The reader is referred to the expert consensus document on CT imaging in patients with CHD of the Society for Cardiovascular Computed Tomography (SCCT) (see Han et al., Further Reading).

Conventional Radiology

Although CHD may be suspected on the basis of the chest x-ray (CXR), the technique precludes the detailed morphological assessment necessary for diagnosis and determination of specific underlying pathology.

The diagnostic accuracy of the CXR in the assessment of infants with asymptomatic murmurs is poor. Despite its poor performance as a screening tool, CHD may be suspected on the basis of a CXR because of higher specificity, but false-positive rates are significant.

The CXR, however, is not dispensable and remains important in the subsequent management of patients with CHD, particularly in three situations:

  • 1.

    Postoperatively, for identification of the position of intravascular catheters, chest drains and endotracheal tubes ( Fig. 13.2A ).

    Fig. 13.2, Perioperative Chest X-Ray.

  • 2.

    Identification of postoperative complications: consolidation, collapse, pleural effusion, pneumothorax, pneumomediastinum or pericardial collections (see Fig. 13.2B ).

  • 3.

    Perioperative, physiological assessment of the lungs and cardiomediastinal contour (see below).

Diagnostic Features

The ubiquity of the CXR in clinical practice warrants discussion of the diagnostic features that should prompt suspicion of CHD. It is suggested that when reporting images, the reader avoid such terms as ‘boot-shaped’ or ‘snowman’ typically associated with specific lesions because they can be misleading and often erroneous. More appropriate is a descriptive consideration of the cardiomediastinal contour and lungs, attempting to evaluate the predominant physiological profile discussed above. The reader may find it helpful to read this section in conjunction with the section on clinical presentation.

The Pulmonary Vasculature

Radiologically normal pulmonary vascularity is present in CHD if the patient is not in heart failure, if no large shunt is present and if there is no significant reduction in pulmonary blood flow: for example, mild PS. The pulmonary vasculature may, however, look normal on the conventional radiograph even in the presence of significant CHD.

Increased pulmonary perfusion (pulmonary plethora) is recognised by enlarged central and peripheral pulmonary arteries and veins in all zones ( Fig. 13.3A ), as occurs in situations with increased pulmonary blood flow: ASD, VSD and PDA with large left-to-right shunts ( Table 13.1 ).

Fig. 13.3, Physiological Assessment Using Chest X-Ray.

TABLE 13.1
Increased Pulmonary Perfusion (Plethora)
Level of Shunt Cardiac Lesion
Atria Ostium secundum ASD a
Ostium primum ASD (partial AVSD)*
Sinus venosus defect
Anomalous pulmonary venous drainage
(partial a ; total b )
Atrioventricular valves Complete AVSD
Partial AVSD a
Ventricle VSD a
Double outlet ventricle b
Single ventricle b
Great vessels PDA a
Aortopulmonary window
Common arterial trunk b
Coronary artery-RV fistula
Transposition of great arteries b
Systemic to pulmonary artery shunts
(unrestrictive BT-shunt)
Other Vein of Galen malformation
ASD, Atrial septal defect; AVSD, atrioventricular septal defect; BT, Blalock–Taussig; PDA, patent ductus arteriosus; RV, right ventricle; VSD, ventricular septal defect.

a Common cause of plethora without cyanosis.

b Common cause of plethora with cyanosis.

Decreased pulmonary perfusion (oligaemia) ( Fig. 13.4 ) is caused by a reduction in pulmonary blood flow and is typically a phenomenon of cyanotic CHD. Dark lungs and sparse pulmonary vascular markings suggest the diagnosis. Image acquisition must be optimal because overexposure will significantly confound correct interpretation. Pulmonary blood flow may be impaired by obstruction to normal flow through the right heart: for example, tricuspid atresia, TOF and PS ( Table 13.2 ).

Fig. 13.4, Pulmonary Oligaemia.

TABLE 13.2
Neonatal Pulmonary Oligaemia
Level Cardiac Lesion
Tricuspid valve Tricuspid atresia
Tricuspid stenosis
Ebstein anomaly
Right ventricular outflow Pulmonary infundibular stenosis (severe)
Pulmonary valvar stenosis (severe)
Tetralogy of Fallot
Pulmonary artery Pulmonary artery atresia
Right or left pulmonary artery interruption (differential lung oligaemia)
Peripheral pulmonary artery stenosis (regional oligaemia)
Transposition of great arteries with pulmonary valve stenosis

Pulmonary venous congestion and oedema (see Fig. 13.3B ) in CHD is caused by functional or anatomical obstruction to pulmonary venous return. In addition to oedema formation caused by increased transvascular pressure gradients, consideration should be given to other pathological processes such as increased vessel leakiness caused by acute lung injuries, for example ( Table 13.3 ). The usual adult pattern of basal oedema, resulting in alveolar hypoxia and constriction of lower pulmonary vasculature and redirection to the apices does not apply to the supine infant. As pulmonary venous pressure increases, there is progressive accumulation of radiological signs, beginning with redistribution (in older children/adults), progressing to interstitial oedema (perivascular haziness, peribronchial cuffing, Kerley B lines, subpleural effusions) and, finally, migration of extravasated fluid centrally, resulting in perihilar alveolar consolidation.

TABLE 13.3
Pulmonary Oedema and Venous Congestion
Level Cardiac Lesion
Pulmonary veins Obstructed TAPVD
Pulmonary vein stenosis
Left atrium Cor triatriatum
Mitral valve stenosis/atresia
Left atrioventricular valve regurgitation
Left ventricle Hypoplastic left ventricle
LV endocardial fibroelastosis
Cardiomyopathy
LV ischaemia-aberrant left coronary artery from pulmonary artery (ALCAPA)
Aorta Aortic stenosis/atresia
Coarctation/interruption of the aorta
Non-cardiac pulmonary oedema Asphyxia
Acute lung injury
Intravenous overhydration
LV, Left ventricle; TAPVD, total anomalous pulmonary venous connection.

Systemic to pulmonary collateral vessels . Abnormal systemic arterial connections to the pulmonary vasculature may occur as an adaptive mechanism to inadequate pulmonary blood flow. This usually occurs in the setting of pulmonary atresia associated with VSD, in which the RV and pulmonary arteries are not in continuity; instead, discrete MAPCAs (major aortopulmonary collateral arteries) and non-discrete networks of bronchial arteries are the source of pulmonary blood flow. It may also occur during staged management of the single ventricle. They may be recognisable by a nodular lung pattern in the central third of the lung parenchyma, with many small, rounded, opacities representing enlarged bronchial arteries seen end-on.

Pulmonary arterial hypertension may complicate unrepaired CHD. Increased pulmonary blood flow caused by left-right shunting in unrepaired ASD, VSD or PDA gradually causes changes in the pulmonary vasculature, which, over time, leads to increased PVR and overt hypertension. The central pulmonary arteries enlarge and the peripheral pulmonary arteries become smaller than normal. In cases where pulmonary pressure exceeds systemic pressure, shunt reversal occurs, resulting in cyanosis—as occurs in Eisenmenger syndrome.

Heart Size, Shape and Position

Abnormalities of the position of the cardiac apex, aortic arch, liver and stomach may be determined from examination of the CXR. The presence of situs inversus and left aortic arch may be discerned; however, this may or may not be associated with underlying CHD. Some assessment of global and regional heart size is possible (see Fig. 13.3B ) and should be described; however, the limitations of CXR in this regard should be considered. In a study comparing echocardiographical assessment of cardiac enlargement in 95 consecutive paediatric outpatients, the sensitivity of the CXR to identify cardiomegaly was only 58.8% (95% confidence index (CI): 32.9 to 81.6), specificity was 92.3% (95% CI: 84.0 to 97.1).

Specific Lesions

In the following discussion lesions have been classed as acyantoic and cyanotic for convenience. It is important to understand, however, that in various situations a lesion typically described in this way may present in the opposite manner, perhaps caused by the presence or absence of a particular morphological feature or the imposition of altered haemodynamics such as elevated PVR. For example, TOF with minimal outflow tract obstruction may have no cyanosis or a VSD that is so large as to facilitate complete intracardiac mixing may produce cyanosis. Furthermore, certain lesions do not fit easily into either category: for example, Ebstein anomaly of the tricuspid valve when mild is acyanotic but in its severe form is cyanotic. Similarly, congenitally corrected TGA, although acyanotic, is better understood when discussed alongside its cyanotic relative, simple TGA. For further illustrations and images, the reader is referred to the imaging atlas on CHD by Sridharan et al (see Further Reading).

Acyanotic Lesions

Septal Defects

Atrial Septal Defects

ASDs are the most common congenital heart defect detected in adults. Irrespective of their type and location, isolated ASDs cause left-to-right shunting at the atrial level. This leads to atrial dilation, predisposing to tachyarrhythmias, and RV volume overload. The degree and direction of atrial shunting can be modified by AV valve function and ventricular compliance. The presence of an ASD is an independent risk factor for thromboembolic stroke. This is caused by the ability of thromboemboli, originating either in the right atrium or venous vasculature, to pass through the ASD into the systemic circulation.

ASDs are, anatomically and developmentally, a heterogeneous group of lesions ( Fig. 13.5A ). The specific nature of the ASD influences the natural history and management of this disease. Ostium secundum defects make up 80% of ASDs and are located in the fossa ovalis (see Fig. 13.5B ). These defects are caused by failure of the septum secundum to form closure of the ostium secundum. Other forms of ASD are more properly termed interatrial communications because they do not occur in the true morphological atrial septum. The ostium primum defect is actually a component of a common AV junction, also known as an AVSD. This defect usually occurs together with some degree of AV valve abnormality. The sinus venosus defect is found at the junction of the right atrium and either one of the caval veins (see Fig. 13.5C ). This type of ASD is less common and is always associated with partial anomalous pulmonary venous drainage. The least common type of ASD occurs in the coronary sinus and is termed an unroofed coronary sinus. In this case, there is deficiency of the coronary sinus wall as it passes behind the left atrium, allowing shunting from left to right through the coronary sinus itself.

Fig. 13.5, Atrial Septal Defects.

The management of ASDs has changed in recent years, particularly with the increasing use of transcatheter ASD closure devices. Previously, surgical closure was only considered when a large left-to-right shunt led to RV volume overload, atrial dilation and symptoms; however, with the advent of transcatheter techniques, management has become more aggressive. Transcatheter techniques are only viable in patients with small-to-medium-sized ostium secundum defects that have adequate margins with which to anchor the device. Deficiency of the anterior or posteroinferior rim of the defect usually precludes transcatheter closure. Patients with large ostium secundum defects, or defects with deficiency of the anterior or posteroinferior rim. or with sinus venosus lesions, usually require operative repair. The clinical aim is to complete ASD closure before the development of cardiac failure or atrial dilation and timing of intervention depends on the haemodynamic status of the patient; thus, evaluation of ASDs requires definition of type and location of the defect, quantification of the net shunt (pulmonary flow: systemic flow (Q p :Q s )), detection of any intra-atrial thrombus, assessment of RV volume and systolic function and visualisation of the pulmonary venous anatomy.

Visualisation of most interatrial communications is possible by transthoracic echocardiography, although sinus venosus or coronary sinus defects are challenging without a high level of suspicion. In addition, detection of pulmonary venous abnormalities is technically difficult using the transthoracic approach. Transoesophageal echocardiography is the main imaging technique used to assess ASDs (particularly at the time of catheter and surgical closure); however, transoesophageal echocardiography cannot be used to accurately quantify the shunt (Q p :Q s ) and it can be difficult to delineate pulmonary venous anatomy. CMR has, therefore, a significant role in the diagnosis and pre-interventional assessment of ASDs.

Three-dimensional whole-heart techniques, with isotropic resolution, allow accurate multiplanar reformatting with no loss of resolution. These techniques allow 3D rendering of the atrial anatomy. Multislice 2D gradient-echo techniques can be used to assess the dynamic 3D anatomy of the defect, and phase-contrast through-plane flow techniques can accurately size the cross-sectional dimensions of the defect. Multiple or fenestrated defects may also be diagnosed.

Haemodynamic assessment is also an important part of the evaluation of ASDs. Invasive catheterisation has historically been used to quantify left-to-right shunts. Quantification of left-to-right shunts using velocity-encoded phase-contrast MRI compares well to invasive catheterisation results (see Fig. 13.5D ). It has the benefit of being non-invasive and does not require exposure to ionising radiation. Ventricular overload can also be accurately assessed using multislice b-SSFP short-axis imaging and can give important information influencing the timing of intervention.

Key imaging goals

  • Assess defect location, diameter and margin size—suitability for device anchorage.

  • Quantify right heart volume and function—assess volume overload.

  • Quantify shunt (see Fig. 13.5D ).

  • Look for sinus venosus defect, which has an associated partially anomalous pulmonary venous drainage.

  • Look for signs suggestive of elevated PVR—RV hypertrophy, systolic flattening of the interventricular septum and notching of the pulmonary artery flow curve.

Atrioventricular Septal Defects

An atrioventricular septal defect (AVSD) is a lesion caused by a deficiency of the tissues that normally interpose the atrial and ventricular chambers ( Fig. 13.6A and C ). The involved tissues include the atrial primum septum, the AV valves and the inlet portion of the ventricular septum. The feature shared by all AVSDs is a common AV junction guarded by a common AV valve, which may have either one or two orifices (see Fig. 13.6A ).

Fig. 13.6, Atrioventricular Septal Defects.

The common AV junction can be discerned by the loss of the usual ‘offset’ of the tricuspid and mitral valves in the normal heart. The valve, even when it has two orifices, is no longer referred to as a mitral and tricuspid valve; instead they are called left and right AV valves. The common valve typically has five leaflets, referred to as the superior bridging, right anterosuperior, right inferior/mural, inferior bridging and left mural leaflets (see Fig. 13.6AB ).

The relative deficiency of the septal structures and the number of valve orifices give rise to the classification as complete (both ASD and VSDs and single valve orifice), intermediate/incomplete (VSD with two valve orifices) and partial (ASD with two valve orifices, also called an ostium primum ASD). Another clinically useful description is the relative size of the ventricular chambers, allowing for classification as balanced (equal-sized ventricles) or unbalanced (disproportionate ventricles). AVSD can be associated with other cardiac abnormalities, including TOF, subaortic stenosis, atrial isomerism and ventricular hypoplasia, which modify the presentation, prognosis and surgical management.

The diagnosis of AVSD is made in the neonatal period on the basis of a transthoracic ECG. Other imaging techniques are usually not required. Surgical repair is carried out at approximately 3 to 4 months of age and certainly before 6 months of age to prevent the development of pulmonary vascular disease. The repair involves closing the septal defects and creating competent left and right valves from the common AV valve tissue. The association of AVSD with trisomy 21 is well known; repair in this group is associated with lower mortality than non-trisomy 21.

Additional imaging techniques including CMR may be useful in the long-term management of patients with repaired AVSD, including surveillance for important late complications such as AV valve regurgitation (see Fig. 13.6C ).

Key imaging goals

  • Assess ventricular proportion—unbalanced ventricle may not be suitable for biventricular repair.

  • Assess valve structure.

  • Identify associated abnormalities—isomerism of the atrial appendages.

  • Quantify ventricular volume and function.

  • Quantify shunt.

  • Evaluate AV valve regurgitation.

You're Reading a Preview

Become a Clinical Tree membership for Full access and enjoy Unlimited articles

Become membership

If you are a member. Log in here